Loading company…
Mestastop develops and studies drugs for cancer, with a focus on metastasis.
Founded in 2018 by Arnab Roy Chowdhury, Mestastop researches metastasis and develops cancer treatments, including drug discovery, repurposing existing medicines, and clinical trial design. The company is based in Bangalore, India, and is at Seed stage. In March 2024, it raised venture funding from Mumbai Angels, 92 Angels, and Malpani Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in